Trade names Incruse Ellipta Protein binding ~89% ChEBI ID 79040 | Routes ofadministration Inhalation (DPI) Molar mass 508.49 g/mol ChemSpider ID 9693857 | |
 | ||
Pregnancycategory US: C (Risk not ruled out) Legal status US: ℞-onlyIn general: ℞ (Prescription only) | ||
How to pronounce umeclidinium bromide incruse ellipta memorizing pharmacology video flashcard
Umeclidinium bromide (trade name Incruse Ellipta, GSK) is a long-acting muscarinic antagonist approved for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is also approved for this indication in combination with vilanterol (as umeclidinium bromide/vilanterol).
References
Umeclidinium bromide Wikipedia(Text) CC BY-SA